The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review

L E Kristensen; R Christensen; H Bliddal; P Geborek; B Danneskiold-Samsøe; T Saxne

doi:10.1080/03009740701607067

The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review

L E Kristensen
, R Christensen
, H Bliddal
, P Geborek
, B Danneskiold-Samsøe
, T Saxne

Research output: Contribution to journal › Journal article › Research › peer-review

Abstract

To compare the efficacy of adalimumab, etanercept, and infliximab in patients with established rheumatoid arthritis (RA) taking concomitant methotrexate (MTX) by calculating the number needed to treat (NNT) using three different methods.

Original language	English
Journal	Scandinavian Journal of Rheumatology
Volume	36
Issue number	6
Pages (from-to)	411-7
Number of pages	7
ISSN	0300-9742
DOIs	https://doi.org/10.1080/03009740701607067
Publication status	Published - 2011

Access to Document

10.1080/03009740701607067

Library access?

Check availability at the Royal Danish Library

Cite this

Kristensen, L. E., Christensen, R., Bliddal, H., Geborek, P., Danneskiold-Samsøe, B., & Saxne, T. (2011). The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review. Scandinavian Journal of Rheumatology, 36(6), 411-7. https://doi.org/10.1080/03009740701607067

The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review. / Kristensen, L E; Christensen, R; Bliddal, H et al.
In: Scandinavian Journal of Rheumatology, Vol. 36, No. 6, 2011, p. 411-7.

Research output: Contribution to journal › Journal article › Research › peer-review

Kristensen, LE, Christensen, R, Bliddal, H, Geborek, P, Danneskiold-Samsøe, B & Saxne, T 2011, 'The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review', Scandinavian Journal of Rheumatology, vol. 36, no. 6, pp. 411-7. https://doi.org/10.1080/03009740701607067

Kristensen LE, Christensen R, Bliddal H, Geborek P, Danneskiold-Samsøe B, Saxne T. The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review. Scandinavian Journal of Rheumatology. 2011;36(6):411-7. doi: 10.1080/03009740701607067

@article{805873d9259a4630b69eea3dd06ab038,

title = "The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review",

abstract = "To compare the efficacy of adalimumab, etanercept, and infliximab in patients with established rheumatoid arthritis (RA) taking concomitant methotrexate (MTX) by calculating the number needed to treat (NNT) using three different methods.",

author = "Kristensen, \{L E\} and R Christensen and H Bliddal and P Geborek and B Danneskiold-Sams{\o}e and T Saxne",

year = "2011",

doi = "10.1080/03009740701607067",

language = "English",

volume = "36",

pages = "411--7",

journal = "Scandinavian Journal of Rheumatology",

issn = "0300-9742",

publisher = "Taylor \& Francis",

number = "6",

}

TY - JOUR

T1 - The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis

T2 - a systematic literature review

AU - Kristensen, L E

AU - Christensen, R

AU - Bliddal, H

AU - Geborek, P

AU - Danneskiold-Samsøe, B

AU - Saxne, T

PY - 2011

Y1 - 2011

N2 - To compare the efficacy of adalimumab, etanercept, and infliximab in patients with established rheumatoid arthritis (RA) taking concomitant methotrexate (MTX) by calculating the number needed to treat (NNT) using three different methods.

AB - To compare the efficacy of adalimumab, etanercept, and infliximab in patients with established rheumatoid arthritis (RA) taking concomitant methotrexate (MTX) by calculating the number needed to treat (NNT) using three different methods.

U2 - 10.1080/03009740701607067

DO - 10.1080/03009740701607067

M3 - Journal article

SN - 0300-9742

VL - 36

SP - 411

EP - 417

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

IS - 6

ER -